We are in the hope business
We need to clearly and compassionately tell the patient story in all of its frustration, confusion, anger, and faith. Its grit. Hope.
How Patient Services are redefining the patient relationship
The focus on a patient-first strategy suggests that even an "around the pill" strategy is not good enough.
The Cambridge Analytica Mess: What does it mean for Pharma?
Pharma marketing increasingly lives in a world of data. What happens in the world of Facebook cannot be ignored.
A New Pharma Renaissance? Three themes from JPM.
This year there was a palatable sense of renewed confidence. The latent fears of a fallow drug pipeline, patent cliffs, and an unstable insurance market seemed to be in the past.
Value Extraction – Mining for Gold in Late-Stage Products
The long tail of data – techniques for turning old pharma products into productive assets
Pharma's digital transformation should start with marketing
Digital allows pharma companies to quickly test and revise promotion tactics in the marketplace to create more wide-reaching and successful campaigns.
Content marketing and its impact on pharma
Physicians and patients are skeptical of purely promotional content. This leads to an opportunity to build trust and differentiation through unbranded content.
The hackathon model and its promise for pharma marketing
Filling the digital gap for pharma
Whenever there is a major paradigm shift in business, there is both a capability and a capacity gap. Rarely do companies have the right people, and enough of them, to fulfill the demands of a new business environment.
Four unique strategies for data in pharma
A significant share of our business focuses on data. We build and manage marketing data analytics and reporting platforms for pharmaceutical brand leaders.
The drugs, Optistavin, Easovartis and Librylin, and names, results, case studies and specific information, referenced in this advertisement are fictional and were created solely for illustrating the digital marketing capabilities of closerlook, inc. Any resemblance to actual drugs, medications, treatments, persons, living or dead, or to actual events, is purely coincidental. closerlook, inc. does not assume and hereby disclaims any liability to any party for any loss, damage or disruption caused by such party’s reliance on the fictitious information contained in this illustration.